抗人 LRRC75A 抗体对
01AB03882
Leucine-rich repeat-containing protein 75A (LRRC75A) is a protein that plays a significant role in cellular signaling and has been implicated in various biological processes, including angiogenesis and inflammation. It contains multiple leucine-rich repeats, which are known to mediate protein-protein interactions. Recent studies have highlighted LRRC75A's involvement in the secretion of vascular endothelial growth factor (VEGF) from bone marrow-derived mesenchymal stem cells (BM-MSCs) under ischemic conditions, suggesting its potential as a biomarker for identifying cell subpopulations with angiogenic properties. Additionally, LRRC75A is associated with inflammatory responses; its antisense long non-coding RNA (LRRC75A-AS1) has been shown to regulate tight junction proteins and modulate immune responses in bovine mastitis models. Dysregulation of LRRC75A and its associated pathways can contribute to disease processes, particularly in cancer and inflammatory conditions.
| 规格 | 起售价 |
|---|---|
| 登录后可查看 | |
技术参数
- 靶点基因名
- LRRC75A
- 基因别名
- C17orf76; FAM211A
- 蛋白别名
- leucine rich repeat containing 75A; LRRC75A
- UniProt
- Q8NAA5
- 物种
- Human
产品详情
- 靶点名称
- LRRC75A
- 蛋白名称
- leucine rich repeat containing 75A
- 蛋白别名
- Leucine-rich repeat-containing protein 75A; Leucine-rich repeat-containing protein FAM211A
- 靶点基因名
- LRRC75A
- 基因别名
- C17orf76; FAM211A
- UniProt
- Q8NAA5
- 来源物种
- Homo sapiens (Human)
- 物种反应性
- Human
背景介绍
Leucine-rich repeat-containing protein 75A (LRRC75A) is a protein that plays a significant role in cellular signaling and has been implicated in various biological processes, including angiogenesis and inflammation. It contains multiple leucine-rich repeats, which are known to mediate protein-protein interactions. Recent studies have highlighted LRRC75A's involvement in the secretion of vascular endothelial growth factor (VEGF) from bone marrow-derived mesenchymal stem cells (BM-MSCs) under ischemic conditions, suggesting its potential as a biomarker for identifying cell subpopulations with angiogenic properties. Additionally, LRRC75A is associated with inflammatory responses; its antisense long non-coding RNA (LRRC75A-AS1) has been shown to regulate tight junction proteins and modulate immune responses in bovine mastitis models. Dysregulation of LRRC75A and its associated pathways can contribute to disease processes, particularly in cancer and inflammatory conditions.